Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats

British Journal of Pharmacology

Volumn 118, Issue 3, 1996, Pages 659-664

  Feron, Olivier ^a   Salomone, Salvatore ^a   Godfraind, Théophile ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Calcium channel blockers; Cardiac hypertrophy; Endothelin; Hypertension; Lacidipine; Salt loading; Stroke prone rats

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; IODINE 125; LACIDIPINE; MESSENGER RNA; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0029941259     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15451.x     Document Type: Article

References (50)

1. CHIRGWIN, J.M., PRZYBYLA, A.E., MCDONALD, R.J. & RUTTER, W.J. (1979). Isolation of biological active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 18, 5294-5299.
2. CRISTOFORI, P., TERRON, A., MICHELI, D., BERTOLINI, G., GAVIRAGHI, G. & CARPI, C. (1991). Vascular protection of lacidipine in salt-loaded DAHL-S rats at nonsustained antihypertensive doses. J. Cardiovas. Pharmacol., 17 (Suppl. 4), S75-S86.
3. DE KEULENAAR, G.W., ANDREIS, L.J., SYS, S.U. & BRUTSAERT, D.L. (1995). Endothelium-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle. Circ. Res., 76, 878-884.
4. DRAYER, J.I., GARDIN, J., BREWER, D.D. & WEBER, M..A. (1987). Disparate relationship between blood pressure and left ventricular mass in patients with and without left ventricular hypertrophy. Hypertension, 9, 61-64.
5. FERON, O., SALOMONE, S. & GODFRAIND, T. (1995a). Influence of salt loading on the cardiac and renal preproendothelin-1 mRNA expression in stroke-prone spontaneously hypertensive rats. Biochem. Biophys. Res. Commun., 209, 161-166.
6. FERON, O., SALOMONE, S. & GODFRAIND, T. (1995b). Inhibition by lacidipine of salt-dependent cardiac hypertrophy and endothelin gene expression in stroke-prone spontaneously hypertensive rats. Biochem. Biophys. Res. Common., 210, 219-224.
7. FU, L.-X., SUN, X.-Y., HEDNER, T., FENG, Q.-P., LIANG, Q.-M., HOEBEKE, J. & HJALMARSON, A. (1993). Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with chronic ischemic heart failure. J. Cardiovasc. Pharmacol., 22, 177-182.
8. GAVIRAGHI, G. & GODFRAIND, T. (1993). New insight into the vascular properties of lacidipine. In Calcium Antagonists: Pharmacology and Clinical Research, ed. Godfraind, T., Govoni, S., Paoletti, R. & Vanhoutte, P.M. pp.65-69. Dordrecht: Kluwer Academic Publishers.
9. GAVIRAGHI, G., MICHELI, M., TERRON, A. & CRISTOFORI, P. (1991). Lacidipine: prevention of vascular damage induced by hypertension. J. Cardiovasc. Pharmacol., 18, S7-S12.
10. GODFRAIND, T., MILLER, R. & WIBO, M. (1986). Calcium antagonists and calcium entry blockade. Pharmacol. Rev., 38, 321-416.
11. HAIZER, D.J., CICILA, G., COCKERHAM, C., GRIENDLING, K.K., DELAFONTAINE, P., CHUNG NG, S. & RUNGE, M.S. (1994). Endothelin A and B receptors are down-regulated in the hearts of hypertensive rats. Am. J. Med. Sci., 307, 222-227.
12. HERBETTE, L.G., GAVIRAGHI, G., TULENKO, T. & MASON, R.P. (1993). Molecular interaction between lacidipine and biological membranes. J. Hypertens., 11, (Suppl. 1), S13-S19.
13. HIRATA, Y., YOSHIMI, H., TAKAICHI, S., YANAGISAWA, M. & MASAKI, T. (1988). Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett., 239, 13-17.
14. HORI, S., KOMATSU, Y., SHIGEMOTO, R., MIZUNO, N. & NAKANISHI, S. (1992). Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology, 130, 1885-1895.
15. ISHIKAWA, T., LI, L., SHINMI, O., KIMURA, S., YANAGISAWA, M., GOTO, K. & MASAKI, T. (1991). Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts. Circ. Res., 69, 918-926.
16. ITO, H., HIRATA, Y., ADACHI, S., TANAKA, M., TSUJINO, M., KOIKE, A., NOGAMI, A., MARUMO, K. & HIROE, M. (1993). Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest., 92, 398-403.
17. ITO, H., HIRATA, Y., HIROKE, M., TSUJINO, M., ADACHI, S., TAKAMOTO, T., NITTA, M., TANIGUCHI, K. & MARUMO, F. (1991). Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ. Res., 69, 209-215.
18. ITO, H., HIROK, M., HIRATA, Y., KUJISAKI, H., ADACHI, S., AKIMOTO, H., OHTA, V. & MARUMO, F. (1994). Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by haemodynamic overload. Circulation, 89, 2198-2203.
19. KANNO, K., HIRATA, Y., TSUJINO, M., IMAI, T., SHICHIRI, M., ITO, H. & MARUMO (1993). Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem. Biophys. Res. Commun., 194, 1282-1287.
20. KIM, S., OHTA, K., HAMAGUCHI, A., OMURA, T., YUKIMURA, T., MIURA, K., INADA, Y., ISHIMURA, Y., CHATANI, K. & IWAO, H. (1995). Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J. Pharmacol. Exp. Ther., 273, 509-515.
21. LABARCA, C. & PAIGEN, K. (1980). A simple, rapid and sensitive DNA assay procedure. Anal. Biochem., 102, 344-352.
22. LARIVIÈRE, R., DAY, R. & SCHIFFRIN, E.L. (1993). Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension, 21, 916-920.
23. LEENEN, F.H.H., SMITH, D.L., FARKAS, R.M., REEVES, R.A. & MARQUEZ-JUKIO, A. (1987). Vasodilators and regression of left ventricular hypertrophy, Hydralazine versus praxosin in hypertensive humans. Am. J. Med., 82, 969-978.
24. LINZ, W., HENNING, R. & SCHOLKENS, B.A. (1991). Role of the angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats. J. Hypertens., 9 (Suppl. 6), S400-S401.
25. LOWRY, O.H., ROSEBROUGH, M.J., FARR, A.K. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. MESSERLI, F.H. & KETELHUT, R. (1991). Left ventricular hypertrophy: an independent risk factor. J. Cardiovasc. Pharmacol., 17 (Suppl. 4), S59-S67.
27. MIZRA, R.P., BONNIS, A., MIRANTI, C.K., RIVERA, V.M., SHENG, M. & GREENBERG, M.E. (1994). L-type voltage-sensitive calcium channel activation stimulates gene expression by a serum-response factor-dependent pathway. J. Biol. Chem., 269, 25483-25493.
28. MOLENAAR, P., O'REILLY, G., SHARKEY, A., KUC, R.E., HARDING, D.P., GRESHAM, G.A. & DAVENPORT, A.P. (1993). Characterization and localization of endothelin receptor sybtypes in the human atrioventricular conducting system and myocardium. Circ. Res., 72, 526-538.
29. MORGAN, H.E. & BAKER, K.M. (1991). Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation, 83, 13-25.
30. MUNSON, P.J. & RODBARD, D. (1980). Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem., 107, 220-239.
31. MURPHY, T.H., WORLEY, P.F. & BARABAN, J.M. (1991). L-type voltage-dependent calcium channels mediate synaptic activation of immediate early genes. Neuron, 7, 625-635.
32. NARA, Y., NABIKA, T., IKEDA, K., SAWAMURA, M., ENDO, J. & YAMORI, Y. (1991). Blood pressure cosegregates with a microsatellite of angiotensin I converting enzyme (ACE) in F2 generation from a cross between original normotensive Wistar-Kyoto rat (WKY) and stroke-prone hypertensive rats (SHRSP). Biochem. Biophys. Res. Commun., 181, 941-946.
33. +)-ATPase inhibition in microsomes from rat heart. Biochem. Pharmacol., 33, 47-53.
34. PAUL, M., ZINTZ, M., BOCKER, W. & DYER, M. (1995). Characterization and functional analysis of the rat endothelin-1 promoter. Hypertension, 25, 683-687.
35. A receptors in the heart. Br. J. Pharmacol., 114, 297-302.
36. ROTH, M., KEUL, R., EMMONS, L.R., HORL, W. & BLOCK, L.H. (1992). Manidipine regulates the transcription of cytokine genes. Proc. Natl. Acad. Sci. U.S.A., 89, 4071-4075.
37. SAKURAI, T., MORIMOTO, H., KASUYA, Y., TAKUWA, Y., NAKAUCHI, H., MASAKI, T. & GOTO, K. (1992). Level of ETB receptor mRNA is down-regulated by ondothelins through decreasing the intracellular stability of mRNA molecules. Biochem. Biophys. Res. Commun., 186, 342-347.
38. SAKURAI, T., YANAGISAWA, M., INOUE, A., RYAN, U.S., KIMURA, S., MITSUI, Y., GOTO, K. & MASAKI, T. (1991). cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun., 175, 44-47, 1991.
39. SALOMONE, S. & GODERAIND, T. (1993). Radioligand and functional estimates of the interaction of 1,4-dihydropyridines, isradipine and laeidipine, with calcium channels in smooth muscle. Br. J. Pharmacol., 109, 100-106.
40. SAMBROOK, J., FRITSCH, F.F. & MANIATIS, T. (1986). Molecular Cloning: a Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
41. SCHIFFRIN, E.L. (1995). Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension, 25, 1135-1143.
42. SHIBOTA, M., NAGAOKA, A., SHINO, A. & FUJITA, T. (1979). Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am. J. Physiol., 236, H409-H416.
43. SHUDO, C., MASUDA, Y., SUGITA, H., FURUKAWA, S., HAYASHI, K., HIRATA, H., TANAKA, S. & TOMITA, K. (1994). Renal-protective effect of efonidipine hydrochloride (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats. Gen. Pharmacol., 25, 1567-1575.
44. STASCH, J.-P., HIRTH-DIETRICH, C., FROBEL, K. & WEGNER, M. (1995). Prolonged endothelin blockade reduces hypertension and cardiac hypertrophy in SHR-SP. J. Cardiorasc. Pharmacol., 26 (Suppl. 3), S436-S438.
45. STIER, C.T., BEMER, I.E., AHMAD, S., ZUO, H., SELIG, N., ROETHEL, S., LEVINE, S. & ITSKOVITZ, H.D. (1989). Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension, 13, 115-121.
46. STIER, C.T., CHANDER, P., GUTSTEIN, W.H., LEVINE, S. & ITSKOVlTZ, H.D. (1991). Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am. J. Hypertens., 4, 680-687.
47. SUNG, C.-P., ARLETH, A.J., STORER, B.L. & OHLSTEIN, E.H. (1994). Angiotensin Type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J. Pharmacol. Exp. Ther., 271, 429-437.
48. SUZUKI, T., HOSHI, H. & MITSUI, Y. (1990). Endothelin stimulates hypertrophy and contractility of neonatal rat cardiac myocytes in a serum-free medium. FEBS Lett., 268, 149-151.
49. VAN AMSTERDAM, F.T.M., ROVERI, A., MAIORINO, M., RATTI, E. & URSINI, F. (1992). Laeidipine: a dihydropyridine calcium antagonist with antioxydant activity. Free Radical Biol. Med., 12, 183-187.
50. VOLPK, M., CAMARGO, M.J.F., MUELLER, F.B., CAMPBELL Jr, W.G., SEALEY, J.E., PECKER, M..S., SOSA, S. & LARAGH, J.H. (1990). Relation of plasma renin to end organ damage and to protection of potassium feeding in stroke-prone hypertensive rats. Hypertension, 15, 318-326.